Health systems will need to be able to provide multiple services to treat and support people recovering from substance use disorder, which requires interaction and communication, said Winston Collins, PhD, program director for substance use services at the John F. Kennedy Behavioral Health Centers.
Health systems will need to be able to provide multiple services to treat and support people recovering from substance use disorder, which requires interaction and communication, said Winston Collins, PhD, program director for substance use services at the John F. Kennedy Behavioral Health Centers.
Transcript
Substance use disorder is sometimes referred to as a disease of despair and is cited by the CDC as one of the reasons US life expectancy is dropping. What kind of partnerships need to be developed by healthcare systems in order to effectively treat the people they serve?
So, it’s going to be rare that those served by our healthcare system are going to only need 1 particular service today, for 1 particular problem. It’s going to be important that there is joint interaction, joint communication among all of the service providers that are involved in the care of every single patient.
Hospitals, for example—have nurse navigators. On the behavioral health side, where I am, we have a new entity now—we’ve has these folk maybe for about 5 years—they’re called certified recovery specialists. The certified recovery specialist is responsible for identifying the treatment needs that the person may bring, as well as the supportive case management needs—housing, food, community or legal services, maybe that person wants to get a GED—that person becomes aware, and that certified recovery specialist is going to be responsible for connecting that individual to all the services that individual needs in order to recover.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More